top of page
Select a topic below:
Search

Optimizing Neuromodulation Strategies for Lennox-Gastaut Syndrome: Insights from Dr. Depobam Samanta
For many patients with Lennox-Gastaut syndrome (LGS), achieving seizure control remains a major challenge—even with highly effective...


Neuronoff Secures $5 Million in DOD and NIH Funding to Advance Minimally Invasive Neuromodulation Platform
Neuronoff, Inc., a trailblazer in minimally invasive neuromodulation, has hit a major milestone—securing $5 million in funding to propel...
Who Can Benefit from TMS?
Transcranial Magnetic Stimulation (TMS) is primarily known for its effectiveness in treating Major Depressive Disorder (MDD),...
bottom of page